Cardiovascular Systems, Inc. (CSII) financial statements (2021 and earlier)

Company profile

Business Address 1225 OLD HWY 8 NW
ST. PAUL, MN 55112
State of Incorp. DE
Fiscal Year End June 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q2
9/30/2020
Q3
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments225223232107109105123
Cash and cash equivalents749318570655974
Short-term investments1511304738444648
Receivables33302531363536
Inventory, net of allowances, customer advances and progress billings33292824211918
Inventory33292824211918
Other undisclosed current assets3332333
Total current assets:293285288164170162180
Noncurrent Assets
Property, plant and equipment28282828272727
Intangible assets, net (including goodwill)1616172021215
Intangible assets, net (excluding goodwill)1616172021215
Other noncurrent assets121278776
Total noncurrent assets:56565256555539
TOTAL ASSETS:349342340220224217219
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46444348524541
Accounts payable14131213171311
Accrued liabilities32303135353229
Deferred revenue2222222
Total current liabilities:48464550534742
Noncurrent Liabilities
Long-term debt and lease obligation22 000 
Operating lease, liability22 000 
Liabilities, other than long-term debt6756777
Deferred revenue4455667
Other liabilities3311111
Other undisclosed noncurrent liabilities19192121212121
Total noncurrent liabilities:27282627282828
Total liabilities:75737177817571
Stockholders' equity
Stockholders' equity attributable to parent274268269143143142148
Common stock0000000
Additional paid in capital643637632491488483477
Accumulated other comprehensive income (loss)000(0)000
Accumulated deficit(369)(369)(363)(348)(345)(341)(330)
Total stockholders' equity:274268269143143142148
TOTAL LIABILITIES AND EQUITY:349342340220224217219

Income statement (P&L) ($ in millions)

12/31/2020
Q2
9/30/2020
Q3
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
Revenues64614361686468
Cost of revenue(14)(13)(10)(12)(14)(13)(13)
Gross profit:50483249555255
Operating expenses(50)(50)(47)(52)(58)(58)(54)
Operating income (loss):0(2)(15)(3)(3)(6)1
Nonoperating income (expense)(0)(0)(0)(0)000
Interest and debt expense(0)(0)(1)(1)(1)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(0)(3)(16)(3)(4)(6)1
Other undisclosed income from continuing operations before income taxes0011100
Income (loss) from continuing operations before income taxes:0(2)(15)(3)(3)(6)2
Income tax expense(0)(0)(0)(0)(0)(0)(0)
Net income (loss) available to common stockholders, diluted:(0)(2)(15)(3)(3)(6)1

Comprehensive Income ($ in millions)

12/31/2020
Q2
9/30/2020
Q3
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
Net income (loss):(0)(2)(15)(3)(3)(6)1
Other undisclosed comprehensive income  0   0
Comprehensive income (loss):(0)(2)(15)(3)(3)(6)2
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)0(0)(0)0 
Comprehensive income (loss), net of tax, attributable to parent:(0)(2)(15)(3)(3)(6)2

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: